DLYT yields 2000000.00% · JNJ yields 2.13%● Live data
📍 DLYT pulled ahead of the other in Year 1
Combined, DLYT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DLYT + JNJ for your $10,000?
Dais Corporation, a nano-structured polymer technology materials company, develops and commercializes products using its nanomaterial. The company offers Aqualyte, a nanomaterial platform made from commercially available polymer resin and industrial grade solvents, which are mixed using a proprietary process with traditional industrial equipment; and ConsERV, a fixed plate energy recovery ventilator that is useful in meeting building indoor fresh air requirements while saving energy and lowering emissions for various forms of heating, ventilation, and air conditioning equipment. It also provides NanoClear, a water clean-up process useful in the creation of potable water from contaminated water, including industrial process wastewater sea, brackish, or wastewater; and PolyCool and NanoAir products, as well as licenses its nano-structure polymer technology. The company was formerly known as Dais Analytic Corporation Inc. and changed its name to Dais Corporation in February 2019. Dais Corporation was incorporated in 1993 and is headquartered in Odessa, Florida.
Full DLYT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.